Real-world effectiveness and drug retention rate of risankizumab in patients with psoriatic arthritis: data from the multicentre GIRRCS cohort

Francesco Caso, Eleonora Celletti, Ilenia Pantano, Francesco Maria Mariani, Azadeh Shariat Panahi, Myriam Di Penta, Riccardo Mattia Ricciardi, Alberto Lo Gullo, Daniele Mauro, Francesca Saracino, Francesco Ursini, Luisa Costa, Raffaele Scarpa, Roberto Giacomelli, Francesco Ciccia, Giuliana Guggino, Paola Cipriani, Piero Ruscitti

Open source

DOI: 10.1080/14712598.2026.2736542
Published: 2026-09-23
Container: Expert Opinion on Biological Therapy
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/14712598.2026.2736542,
  title = {Real-world effectiveness and drug retention rate of risankizumab in patients with psoriatic arthritis: data from the multicentre GIRRCS cohort},
  author = {Francesco Caso and Eleonora Celletti and Ilenia Pantano and Francesco Maria Mariani and Azadeh Shariat Panahi and Myriam Di Penta and Riccardo Mattia Ricciardi and Alberto Lo Gullo and Daniele Mauro and Francesca Saracino and Francesco Ursini and Luisa Costa and Raffaele Scarpa and Roberto Giacomelli and Francesco Ciccia and Giuliana Guggino and Paola Cipriani and Piero Ruscitti},
  year = {2026},
  journal = {Expert Opinion on Biological Therapy},
  doi = {10.1080/14712598.2026.2736542},
  url = {https://doi.org/10.1080/14712598.2026.2736542}
}

RIS

TY  - JOUR
TI  - Real-world effectiveness and drug retention rate of risankizumab in patients with psoriatic arthritis: data from the multicentre GIRRCS cohort
AU  - Francesco Caso
AU  - Eleonora Celletti
AU  - Ilenia Pantano
AU  - Francesco Maria Mariani
AU  - Azadeh Shariat Panahi
AU  - Myriam Di Penta
AU  - Riccardo Mattia Ricciardi
AU  - Alberto Lo Gullo
AU  - Daniele Mauro
AU  - Francesca Saracino
AU  - Francesco Ursini
AU  - Luisa Costa
AU  - Raffaele Scarpa
AU  - Roberto Giacomelli
AU  - Francesco Ciccia
AU  - Giuliana Guggino
AU  - Paola Cipriani
AU  - Piero Ruscitti
PY  - 2026
JO  - Expert Opinion on Biological Therapy
DO  - 10.1080/14712598.2026.2736542
UR  - https://doi.org/10.1080/14712598.2026.2736542
ER  -

APA

Caso, F., Celletti, E., Pantano, I., Mariani, F. M., Panahi, A. S., Penta, M. D., Ricciardi, R. M., Gullo, A. L., Mauro, D., Saracino, F., Ursini, F., Costa, L., Scarpa, R., Giacomelli, R., Ciccia, F., Guggino, G., Cipriani, P., & Ruscitti, P. (2026). Real-world effectiveness and drug retention rate of risankizumab in patients with psoriatic arthritis: data from the multicentre GIRRCS cohort. Expert Opinion on Biological Therapy. https://doi.org/10.1080/14712598.2026.2736542

Source records

crossref · retrieved 2026-09-26T08:56:24.760Z